Unlock instant, AI-driven research and patent intelligence for your innovation.

Tethered interleukin-15 and interleukin-21

A cell, host cell technology, applied in the direction of interleukins, receptors/cell surface antigens/cell surface determinants, cytokines/lymphokines/interferons, etc., can solve T cell persistence, survival and anti-tumor activity lowering etc.

Pending Publication Date: 2020-10-30
UNITED STATES OF AMERICA
View PDF22 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, obstacles to the overall success of adoptive cell therapy remain
For example, in some cases, after adoptive transfer, the in vivo persistence, survival, and antitumor activity of transferred T cells were reduced

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tethered interleukin-15 and interleukin-21
  • Tethered interleukin-15 and interleukin-21
  • Tethered interleukin-15 and interleukin-21

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0191] This example demonstrates that cells transduced with TeIL-15 Lr1 exhibit superior proliferation in the absence of exogenous IL-2 compared to other IL-15 constructs in Table 2.

[0192] PBMCs were cultured in AIM V medium supplemented with IL-2 (300 IU / mL) and anti-CD3 antibody (OKT3, 50 ng / mL) for 2 days. Cells were then transduced with lentiviruses containing the TeIL-15 Lr1, TeIL-15 Lr2, IL-15 RA, TeIL-15 Lr6, or IL-15S constructs in Table 2. The same number of cells transduced with each IL-15 construct was plated on day 0 when IL-2 was withdrawn from the medium at day 7 post-transduction ( figure 2 ). through the figure 2 Proliferation of transduced cells was assessed using the trypan blue assay to assess the total number of viable cells at each of the different time points indicated. Untransduced cells were used as negative controls. Untransduced cells cultured in the presence of exogenous IL-15 were used as positive controls.

[0193] The results are shown i...

Embodiment 2

[0195] This example demonstrates that cells transduced with the TeIL-15 Lr1 construct exhibit the highest IL- 15 expression levels.

[0196] PBMC were transduced with lentiviruses containing the TeIL-15 Lr1, TeIL-15 Lr2, IL-15 RA or IL-15S constructs in Table 2 as described in Example 1. The presence of IL-15 expressed on the cell membrane was analyzed by flow cytometry. Cells transduced with the TeIL-15Lr1 construct exhibited Highest IL-15 expression level (62.3%).

Embodiment 3

[0198] This example demonstrates that 293T cells transduced with the TeIL-21 Lr6, TeIL-21 Lr1 or TeIL-21 Lr2 constructs in Table 4 express IL-21 on the cell surface.

[0199] Cells (293T) were transduced with lentiviruses containing the TeIL-21 Lr7, TeIL-21 Lr6, TeIL-21 Lr1 or TeIL-21 Lr2 constructs in Table 4. Unstained cells and stained but not transduced cells were used as negative controls.

[0200] TeIL-21 expression was analyzed by flow cytometry. The results are shown in Table 7. As shown in Table 7, more than 30% of 293T cells transduced with TeIL-21 Lr6, TeIL-21 Lr1 or TeIL-21 Lr2 expressed IL-21.

[0201] Table 7

[0202]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed are nucleic acids and polypeptides which provide the co-expression of interleukin (IL)-21 and IL-15 by a host cell, each interleukin being bound to the cell membrane by a cell membrane anchor moiety. Also disclosed are related recombinant expression vectors, host cells, populations of cells, pharmaceutical compositions, and methods of treating or preventing cancer.

Description

[0001] Cross References to Related Applications [0002] This patent application claims the benefit of U.S. Provisional Patent Application No. 62 / 628,454, filed February 9, 2018, which is hereby incorporated by reference in its entirety. [0003] Statement Regarding Federal Funding for Research and Development [0004] This invention was made with government support from the National Cancer Institute of the National Institutes of Health under grant number ZIABC011478. The government has certain rights in this invention. [0005] Incorporation by reference of electronically submitted materials [0006] Incorporated herein by reference in its entirety is the computer-readable nucleotide / amino acid sequence listing filed concurrently with this document and identified as follows: a copy entitled "741568_ST25.TXT" dated February 7, 2019 71,216 byte ASCII (text) file. [0007] Background of the invention [0008] Adoptive cell therapy is effective in treating cancer in some patie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/62C07K14/54
CPCC07K14/5443C12N15/86C12N5/0636A61K48/005A61K48/0008A61K38/2086A61P35/00A61P35/02C12N2740/15043C12N2510/00C07K2319/02C12N15/62C07K2319/00A61K39/4632A61K39/4611A61K39/464491A61K39/46444A61K39/464838A61K2239/38A61K2239/59A61K2239/31A61K39/4631C07K14/7051C07K2319/03C12N15/867
Inventor 克里斯蒂安·S·欣里西斯本杰明·Y·金
Owner UNITED STATES OF AMERICA